Myriad Genetics, Inc.
NASDAQ:MYGN
28.29 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 678.4 | 690.6 | 557 | 851.1 | 851.1 | 772.6 | 771.4 | 753.8 | 723.1 | 778.216 | 613.165 | 496.005 | 402.084 | 362.648 | 326.527 | 333.629 | 157.126 | 114.279 | 82.406 | 56.648 | 64.321 | 53.836 | 45.162 | 34.013 | 25.3 | 23.2 | 15.2 | 6.6 |
| Cost of Revenue
| 202 | 197.6 | 178.2 | 201 | 201 | 177.2 | 171.2 | 157.3 | 147.4 | 109.201 | 79.618 | 64.659 | 46.714 | 44.286 | 43.267 | 32.34 | 30.813 | 27.644 | 20.322 | 13.751 | 12.553 | 10.717 | 7.403 | 0.702 | -0.1 | -1.9 | -2.2 | -1.6 |
| Gross Profit
| 476.4 | 493 | 378.8 | 650.1 | 650.1 | 595.4 | 600.2 | 596.5 | 575.7 | 669.015 | 533.547 | 431.346 | 355.37 | 318.362 | 283.26 | 301.289 | 126.313 | 86.635 | 62.084 | 42.897 | 51.768 | 43.12 | 37.759 | 33.311 | 25.4 | 25.1 | 17.4 | 8.2 |
| Gross Profit Ratio
| 0.702 | 0.714 | 0.68 | 0.764 | 0.764 | 0.771 | 0.778 | 0.791 | 0.796 | 0.86 | 0.87 | 0.87 | 0.884 | 0.878 | 0.867 | 0.903 | 0.804 | 0.758 | 0.753 | 0.757 | 0.805 | 0.801 | 0.836 | 0.979 | 1.004 | 1.082 | 1.145 | 1.242 |
| Reseach & Development Expenses
| 85.4 | 81.9 | 80.9 | 85.9 | 85.9 | 70.8 | 74.4 | 70.6 | 75.5 | 67.476 | 53.706 | 42.645 | 27.751 | 21.873 | 17.914 | 139.715 | 100.708 | 83.757 | 59.243 | 50.697 | 47.589 | 36.295 | 33.818 | 28.099 | 23.5 | 23 | 18.6 | 13 |
| General & Administrative Expenses
| 514.7 | 599.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 514.7 | 599.8 | 500.7 | 555.5 | 555.5 | 467.1 | 476.4 | 359.1 | 366 | 327.097 | 251.839 | 208.383 | 169.841 | 161.414 | 138.884 | 123.493 | 73.332 | 48.467 | 43.586 | 34.835 | 31.525 | 25.485 | 17.078 | 13.475 | 11.1 | 11.8 | 8.8 | 2.5 |
| Other Expenses
| 0.6 | 139.3 | 0 | 1.2 | 1.2 | -0.4 | -2.5 | 1.2 | 0.3 | -1.974 | -0.223 | -0.407 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.285 | 3.2 | 3.3 | 2.5 | 1.6 |
| Operating Expenses
| 600.1 | 681.7 | 653.3 | 641.4 | 641.4 | 537.9 | 550.8 | 429.7 | 441.5 | 394.573 | 305.545 | 251.028 | 197.592 | 183.287 | 156.798 | 263.208 | 174.04 | 132.224 | 102.829 | 85.532 | 79.114 | 61.78 | 50.896 | 44.858 | 37.8 | 38.1 | 29.9 | 17.1 |
| Operating Income
| -123.7 | -48.7 | -194.8 | 7.6 | 7.6 | 118.7 | 49.4 | 166.8 | 134.2 | 274.442 | 228.002 | 180.318 | 157.778 | 135.075 | 126.462 | 38.081 | -47.727 | -45.589 | -40.745 | -42.635 | -27.346 | -18.66 | -13.137 | -11.547 | -12.4 | -13 | -12.5 | -8.9 |
| Operating Income Ratio
| -0.182 | -0.071 | -0.35 | 0.009 | 0.009 | 0.154 | 0.064 | 0.221 | 0.186 | 0.353 | 0.372 | 0.364 | 0.392 | 0.372 | 0.387 | 0.114 | -0.304 | -0.399 | -0.494 | -0.753 | -0.425 | -0.347 | -0.291 | -0.339 | -0.49 | -0.56 | -0.822 | -1.348 |
| Total Other Income Expenses Net
| -16.9 | -8.4 | -88.9 | 0.1 | 0.1 | 60.8 | -1.7 | 1.2 | 0.3 | -1.974 | -0.223 | -0.407 | -0.353 | 0.099 | -2.493 | -3.337 | 0.653 | -0.012 | -2.031 | -0.01 | 0.038 | -0.214 | -0.305 | -0.383 | 12.4 | 3.2 | 3.3 | 3.1 |
| Income Before Tax
| -140.6 | -57.1 | -283.7 | 0.2 | 7.7 | 116.9 | 42.9 | 168.9 | 134.9 | 277.865 | 233.276 | 184.54 | 159.651 | 140.834 | 136.447 | 48.453 | -34.962 | -38.189 | -39.978 | -40.62 | -24.408 | -13.489 | -6.591 | -8.722 | -10 | -9.8 | -9.2 | -5.9 |
| Income Before Tax Ratio
| -0.207 | -0.083 | -0.509 | 0 | 0.009 | 0.151 | 0.056 | 0.224 | 0.187 | 0.357 | 0.38 | 0.372 | 0.397 | 0.388 | 0.418 | 0.145 | -0.223 | -0.334 | -0.485 | -0.717 | -0.379 | -0.251 | -0.146 | -0.256 | -0.395 | -0.422 | -0.605 | -0.894 |
| Income Tax Expense
| -28.6 | -29.9 | 59.9 | -4.4 | -4.4 | -13.9 | 21.3 | 43.6 | 54.7 | 101.64 | 86.137 | 72.389 | 58.941 | -11.469 | 0.193 | 0.608 | 34.962 | -7.4 | -0.767 | -2.015 | 0.417 | 0.5 | 0.583 | 8.722 | 10 | 9.8 | 9.2 | 5.9 |
| Net Income
| -112 | -27.2 | -223.7 | 4.6 | 4.6 | 131 | 21.8 | 125.3 | 80.2 | 176.225 | 147.139 | 112.151 | 100.71 | 152.303 | 84.615 | 47.845 | -34.962 | -38.189 | -39.978 | -40.62 | -24.825 | -13.989 | -7.174 | -8.722 | -10 | -9.8 | -9.2 | -5.9 |
| Net Income Ratio
| -0.165 | -0.039 | -0.402 | 0.005 | 0.005 | 0.17 | 0.028 | 0.166 | 0.111 | 0.226 | 0.24 | 0.226 | 0.25 | 0.42 | 0.259 | 0.143 | -0.223 | -0.334 | -0.485 | -0.717 | -0.386 | -0.26 | -0.159 | -0.256 | -0.395 | -0.422 | -0.605 | -0.894 |
| EPS
| -1.39 | -0.35 | -2.99 | 0.063 | 0.06 | 1.89 | 0.32 | 1.79 | 1.12 | 2.33 | 1.82 | 1.33 | 1.12 | 1.58 | 0.91 | 0.54 | -0.43 | -0.53 | -0.65 | -0.74 | -0.48 | -0.3 | -0.16 | -0.22 | -0.27 | -0.26 | -0.26 | -0.2 |
| EPS Diluted
| -1.39 | -0.35 | -2.99 | 0.061 | 0.06 | 1.82 | 0.32 | 1.71 | 1.08 | 2.25 | 1.77 | 1.3 | 1.1 | 1.54 | 0.86 | 0.51 | -0.43 | -0.53 | -0.65 | -0.74 | -0.48 | -0.3 | -0.16 | -0.22 | -0.27 | -0.26 | -0.26 | -0.2 |
| EBITDA
| -67.8 | 14.1 | -123.4 | 86.1 | 86.1 | 113.3 | 96.4 | 193.5 | 159.2 | 274.442 | 228.002 | 180.318 | 158.131 | 134.976 | 138.404 | 50.199 | -40.836 | -38.722 | -32.622 | -36.859 | -22.109 | -13.949 | -9.103 | -7.879 | -9.2 | -12.9 | -13.3 | -10.4 |
| EBITDA Ratio
| -0.1 | 0.02 | -0.222 | 0.101 | 0.101 | 0.147 | 0.125 | 0.257 | 0.22 | 0.353 | 0.372 | 0.364 | 0.393 | 0.372 | 0.424 | 0.15 | -0.26 | -0.339 | -0.396 | -0.651 | -0.344 | -0.259 | -0.202 | -0.232 | -0.364 | -0.556 | -0.875 | -1.576 |